Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech IPO
Biotech
Odyssey abandons IPO plans as 'not in best interests of company'
Odyssey Therapeutics has bailed on its long-awaited public listing in further evidence that the IPO window remains firmly shut for now.
James Waldron
Jun 10, 2025 7:25am
'One of the lucky few': Bicara CEO on last year's $326M IPO
Apr 14, 2025 3:59pm
Market volatility adds to 'already challenging' year for IPOs
Apr 11, 2025 9:25am
BioNTech backing powers DualityBio toward $200M Hong Kong IPO
Apr 7, 2025 8:21am
Deerfield suit says Alcon committed 'Valentine's Day massacre'
Feb 24, 2025 5:20pm
Aardvark secures $94M IPO to fund appetite-suppressant trials
Feb 13, 2025 8:10am
